Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J.
Human Cell 7(3): 167-171
1994
ISSN/ISBN: 0914-7470 PMID: 7873501 Document Number: 429744
Seven cell lines, MOLM-6, -7, -8, -9, -10, -11 and -12, were established from a single blood sample from a patient with chronic myelogenous leukemia (CML) in blastic phase having the Ph1 chromosome abnormality. Based on immunophenotyping, two of these seven cell lines, MOLM-7 and -11, represented the megakaryoblastoid lineage, and the other five cell lines represented two different maturation stages of the myeloid lineage.
Document emailed within 1 workday
Related Documents
Chesebro, B.; Wehrly, K.; Housman, D. 1978: Lack of erythroid characteristics in Ia-positive leukemia cell lines induced by Friend murine leukemia virus: brief communication Journal of the National Cancer Institute 60(1): 239-242Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S. 2003: Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran Haematologica 88(4): Elt13
Watanabe, T.; Kataoka, T.; Mizuta, S.; Kobayashi, M.; Uchida, T.; Imai, K.; Wada, H.; Kinoshita, T.; Murate, T.; Mizutani, S. 1995: Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein Leukemia 9(11): 1926-1934
Drach, J.; Lopez-Berestein, G.; McQueen, T.; Andreeff, M.; Mehta, K. 1993: Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid Cancer Research 53(9): 2100-2104
O'Brien, S.G.; Kirkland, M.A.; Melo, J.V.; Rao, M.H.; Davidson, R.J.; McDonald, C.; Goldman, J.M. 1994: Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines Leukemia 8(12): 2156-2162
Kishi, K.; Takahashi, M.; Aoki, S.; Nagai, K.; Hirosawa, H.; Koike, T.; Sakai, C.; Aoyagi, Y.; Sanada, M.; Moriyama, Y. 1984: A new Ph1 positive cell line (KU812) from a patient with blastic crisis of chronic myelogenous leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(3): 709-718
Tange, T.; Nakahara, K.; Mitani, K.; Yamasaki, I.; Yasuda, H.; Tanaka, F.; Mizuguchi, M.; Oda, H.; Yatomi, Y.; Takanashi, R. 1988: Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis Cancer Research 48(21): 6137-6144
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Preisler, H.D.; Raza, A.; Higby, D.; Kirshner, J.; Woll, J.; Bennett, J.; Winton, L.; Weiner, R.; Richman, C.; Golomb, H. 1984: Treatment of myeloid blastic crisis of chronic myelogenous leukemia Cancer Treatment Reports 68(11): 1351-1355
Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T. 1991: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplantation Proceedings 23(1 Pt 2): 1695-1696
Carbonell, F.; Grilli, G. 1981: Cytogenetical changes in Philadelphia chromosome-positive chronic myelogenous leukemia Medicina Clinica 77(10): 420-423
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Mazza, P.; Amurri, B.; Palazzo, G.; Prudenzano, A.; Pricolo, G.; Stani, L. 2000: Fludarabine containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience Haematologica 85(2): 222-224
Tanaka, M.; Tanaka, K.; Oizumi, K. 1999: Coexistence of multiple myeloma and chronic myelogenous leukemia International Journal of Hematology 70(2): 132-133
Fujii, H.; Seki, S.; Misawa, S.; Sonoda, Y.; Kita, K. 1983: Ph1-positive chronic myelogenous leukemia with simultaneous erythroblastic and monoblastic transformation Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 46(5): 1056-1069
Talpaz, M.; Kantarjian, H.; Kurzrock, R.; Gutterman, J.U. 1989: Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia Bone Marrow Transplantation 4(Suppl 1): 63
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Bee, P.C.; Gan, G.G.; Sangkar, V.J.; Haris, A.R. 2008: Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation Medical Journal of Malaysia 63(1): 71-72
Nitta, M.; Tsuboi, K.; Yamashita, S.; Kato, M.; Hayami, Y.; Harada, S.; Komatsu, H.; Iida, S.; Banno, S.; Wakita, A.; Ueda, R. 1999: Multiple myeloma preceding the development of chronic myelogenous leukemia International Journal of Hematology 69(3): 170-173